Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Long-Term Safety and Efficacy of Lunsekimig for Adults with Chronic Rhinosinusitis with Nasal Polyps

    Not recruiting

    2 1 1
    Investigated Drugs:
    Belgium Bulgaria Poland
  • Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps

    Not recruiting

    3 1
    Investigated Drugs:
    Austria Finland Germany Hungary Italy The Netherlands +4
  • Study on Symptom Changes in Adults with Chronic Rhinosinusitis with Nasal Polyps Using Tezepelumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Bulgaria France Germany Hungary Italy Poland +1
  • Study on Stopping Mepolizumab or Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps After 12 Months Symptom-Free

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Denmark
  • Study on the Effects of SAR443765 and Mometasone Furoate in Adults with Chronic Rhinosinusitis with Nasal Polyps

    Not recruiting

    2 1 1
    Belgium Bulgaria Poland
  • Study on Benralizumab and Mometasone Furoate for Patients with Severe Eosinophilic Chronic Rhinosinusitis with Nasal Polyps and Asthma

    Not recruiting

    3 1 1
    Belgium Bulgaria Hungary Italy Poland
  • Study on the Effects of Verekitug (UPB-101) for Patients with Chronic Rhinosinusitis with Nasal Polyps Using Nasal Corticosteroids

    Not recruiting

    2 1
    Czechia Germany Poland Spain
  • Study on the Effect of Dupilumab for Patients with Chronic Rhinosinusitis with Nasal Polyps

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria
  • Study Comparing Dupilumab and Mepolizumab for Treating Chronic Rhinosinusitis with Nasal Polyps in Danish Patients

    Not recruiting

    3 1 1 1
    Denmark
  • Study on the Effects of Dupilumab for Patients with Chronic Rhinosinusitis with Nasal Polyps

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium